Tvardi Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2013 to Q4 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tvardi Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2013 to Q4 2024.
  • Tvardi Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -756 %, a 519% decline year-over-year.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2024 was -756 %, a 519% decline from 2023.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2023 was -122 %, a 169% decline from 2022.
  • Tvardi Therapeutics, Inc. annual Return On Equity for 2022 was -45.5 %, a 11.6% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2024 -756 -634 -519% Oct 1, 2024 Dec 31, 2024
Q3 2024 -385 -290 -305% Jul 1, 2024 Sep 30, 2024
Q2 2024 -241 -166 -218% Apr 1, 2024 Jun 30, 2024
Q1 2024 -174 -125 -253% Jan 1, 2024 Mar 31, 2024
Q4 2023 -122 -76.6 -169% Oct 1, 2023 Dec 31, 2023
Q3 2023 -95.1 -52 -121% Jul 1, 2023 Sep 30, 2023
Q2 2023 -75.8 -44.3 -141% Apr 1, 2023 Jun 30, 2023
Q1 2023 -49.3 -5.19 -11.8% Jan 1, 2023 Mar 31, 2023
Q4 2022 -45.5 -4.73 -11.6% Oct 1, 2022 Dec 31, 2022
Q3 2022 -43.1 -53.9 -502% Jul 1, 2022 Sep 30, 2022
Q2 2022 -31.5 -35.6 -864% Apr 1, 2022 Jun 30, 2022
Q1 2022 -44.1 -51.6 -688% Jan 1, 2022 Mar 31, 2022
Q4 2021 -40.7 -45.7 -921% Oct 1, 2021 Dec 31, 2021
Q3 2021 10.7 +75.1 Jul 1, 2021 Sep 30, 2021
Q2 2021 4.12 +70.1 Apr 1, 2021 Jun 30, 2021
Q1 2021 7.5 +76.3 Jan 1, 2021 Mar 31, 2021
Q4 2020 4.96 +74.4 Oct 1, 2020 Dec 31, 2020
Q3 2020 -64.4 +5.99 +8.52% Jul 1, 2020 Sep 30, 2020
Q2 2020 -66 +2.39 +3.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 -68.8 -1.53 -2.27% Jan 1, 2020 Mar 31, 2020
Q4 2019 -69.5 -0.33 -0.48% Oct 1, 2019 Dec 31, 2019
Q3 2019 -70.4 +0.47 +0.66% Jul 1, 2019 Sep 30, 2019
Q2 2019 -68.4 +4.85 +6.63% Apr 1, 2019 Jun 30, 2019
Q1 2019 -67.3 -9.9 -17.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -69.1 +2.57 +3.59% Oct 1, 2018 Dec 31, 2018
Q3 2018 -70.8 +20.7 +22.6% Jul 1, 2018 Sep 30, 2018
Q2 2018 -73.2 +26.4 +26.5% Apr 1, 2018 Jun 30, 2018
Q1 2018 -57.4 +60 +51.1% Jan 1, 2018 Mar 31, 2018
Q4 2017 -71.7 +4.68 +6.13% Oct 1, 2017 Dec 31, 2017
Q3 2017 -91.5 -40.9 -80.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -99.6 -61.2 -159% Apr 1, 2017 Jun 30, 2017
Q1 2017 -117 -82.9 -241% Jan 1, 2017 Mar 31, 2017
Q4 2016 -76.4 -44.4 -139% Oct 1, 2016 Dec 31, 2016
Q3 2016 -50.6 -20.3 -67.2% Jul 1, 2016 Sep 30, 2016
Q2 2016 -38.4 +4.42 +10.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 -34.5 +0.82 +2.32% Jan 1, 2016 Mar 31, 2016
Q4 2015 -32 -1.56 -5.13% Oct 1, 2015 Dec 31, 2015
Q3 2015 -30.3 +18.9 +38.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 -42.9 +228 +84.2% Apr 1, 2015 Jun 30, 2015
Q1 2015 -35.3 -56.3 -268% Jan 1, 2015 Mar 31, 2015
Q4 2014 -30.4 -38 -503% Oct 1, 2014 Dec 31, 2014
Q3 2014 -49.1 Jul 1, 2014 Sep 30, 2014
Q2 2014 -271 Apr 1, 2014 Jun 30, 2014
Q1 2014 21 Jan 1, 2014 Mar 31, 2014
Q4 2013 7.56 Oct 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.